{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:27:50Z","timestamp":1780100870500,"version":"3.54.0"},"reference-count":47,"publisher":"American Chemical Society (ACS)","issue":"9","funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP325013"],"award-info":[{"award-number":["MOP325013"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol. Pharmaceutics"],"published-print":{"date-parts":[[2018,9,4]]},"DOI":"10.1021\/acs.molpharmaceut.8b00217","type":"journal-article","created":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T20:15:32Z","timestamp":1528143332000},"page":"3672-3681","source":"Crossref","is-referenced-by-count":32,"title":["Codelivery of Paclitaxel and Everolimus at the Optimal Synergistic Ratio: A Promising Solution for the Treatment of Breast Cancer"],"prefix":"10.1021","volume":"15","author":[{"given":"Loujin","family":"Houdaihed","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto M5S 3M2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Evans","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto M5S 3M2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4916-3965","authenticated-orcid":true,"given":"Christine","family":"Allen","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto M5S 3M2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2018,6,4]]},"reference":[{"key":"ref1\/cit1","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2011.139"},{"key":"ref2\/cit2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2012.02.011"},{"key":"ref3\/cit3","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(01)00171-X"},{"key":"ref4\/cit4","doi-asserted-by":"publisher","DOI":"10.3747\/co.21.1966"},{"issue":"4","key":"ref5\/cit5","first-page":"342","volume":"12","author":"Lee J. J. X.","year":"2015","journal-title":"Cancer Biol. Med."},{"key":"ref6\/cit6","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0361"},{"key":"ref7\/cit7","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12405"},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2014.01.001"},{"key":"ref9\/cit9","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu124"},{"key":"ref10\/cit10","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604851"},{"key":"ref11\/cit11","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-017-0839-0"},{"key":"ref12\/cit12","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00051-0"},{"key":"ref13\/cit13","unstructured":"Approved Drugs - FDA approves liposome-encapsulated\ncombination of\ndaunorubicin-cytarabine for adults with some types of poor prognosis\nAML. https:\/\/www.fda.gov\/Drugs\/InformationOnDrugs\/ApprovedDrugs\/ucm569950.htm (accessed October 23, 2017)."},{"key":"ref14\/cit14","doi-asserted-by":"crossref","first-page":"7000","DOI":"10.1200\/JCO.2016.34.15_suppl.7000","volume":"34","author":"Lancet J. E.","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref15\/cit15","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S3061"},{"key":"ref16\/cit16","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-013-2630-y"},{"key":"ref17\/cit17","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.7b00188"},{"key":"ref18\/cit18","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.8b00037"},{"key":"ref19\/cit19","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-1947"},{"key":"ref20\/cit20","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2006.09.047"},{"key":"ref21\/cit21","unstructured":"Eetezadi, S. Nanomedicines and Combination Therapy of Doxorubicin and Olaparib for Treatment of Ovarian Cancer, Ph.D. Thesis, University of Toronto, 2016."},{"key":"ref22\/cit22","first-page":"669","volume":"5","author":"Zhao D. Z.","year":"2010","journal-title":"Int. J. Nanomedicine"},{"key":"ref23\/cit23","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2889"},{"key":"ref24\/cit24","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.162339"},{"key":"ref25\/cit25","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-1109"},{"key":"ref26\/cit26","doi-asserted-by":"publisher","DOI":"10.1124\/pr.58.3.10"},{"key":"ref27\/cit27","doi-asserted-by":"publisher","DOI":"10.1016\/0065-2571(84)90007-4"},{"issue":"3","key":"ref28\/cit28","first-page":"621","volume":"67","author":"Chou T.","year":"2010","journal-title":"J. Food Compos. Anal."},{"key":"ref29\/cit29","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2008.06.028"},{"key":"ref30\/cit30","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-09-0243"},{"issue":"6","key":"ref31\/cit31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1634\/theoncologist.2002-0013","volume":"7","author":"Miles D.","year":"2002","journal-title":"Oncologist"},{"key":"ref32\/cit32","doi-asserted-by":"publisher","DOI":"10.1021\/bm501285t"},{"issue":"1","key":"ref33\/cit33","first-page":"3047","volume":"1848","author":"Pathogens S.","year":"2016","journal-title":"HHS Public Access"},{"key":"ref34\/cit34","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr608"},{"key":"ref35\/cit35","unstructured":"Paclitaxel. https:\/\/reference.medscape.com\/drug\/taxol-paclitaxel-342187 (accessed January 19, 2018)."},{"key":"ref36\/cit36","unstructured":"Everolimus. https:\/\/reference.medscape.com\/drug\/afinitor-zortress-everolimus-999101 (accessed January 19, 2018)."},{"key":"ref37\/cit37","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3003651"},{"key":"ref38\/cit38","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2012.01.002"},{"key":"ref39\/cit39","doi-asserted-by":"publisher","DOI":"10.1021\/bm100073s"},{"key":"ref40\/cit40","doi-asserted-by":"publisher","DOI":"10.1016\/S0927-7765(99)00058-2"},{"key":"ref41\/cit41","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2017.01.069"},{"issue":"6","key":"ref42\/cit42","first-page":"446","volume":"63","author":"Wang Y.","year":"2008","journal-title":"Pharmazie"},{"key":"ref43\/cit43","doi-asserted-by":"publisher","DOI":"10.1186\/s11671-016-1509-3"},{"key":"ref44\/cit44","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.2011.01376.x"},{"key":"ref45\/cit45","doi-asserted-by":"publisher","DOI":"10.1021\/la0502084"},{"key":"ref46\/cit46","doi-asserted-by":"publisher","DOI":"10.1021\/bm201479t"},{"key":"ref47\/cit47","doi-asserted-by":"publisher","DOI":"10.1021\/mp400315p"}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.8b00217","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T11:52:36Z","timestamp":1682596356000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acs.molpharmaceut.8b00217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,4]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9,4]]}},"alternative-id":["10.1021\/acs.molpharmaceut.8b00217"],"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b00217","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,4]]}}}